Rare Disease Treatment Abroad — Advanced Therapies in Japan & South Korea for International Patients

When those standard medicines stop working, South Korea and Japan provide real and regulated alternatives. From those government-approved stem cell programs for fast-tracking the access to Japan’s ARMT act, Emerge Medical connects the patients with the incurable and rare conditions to the specialist care that cannot be available in their home country.

Knee and Joint Replacement
Knee Replacement
Joint Replacement in India

When Doctors Say There Are No More Options There May Still Be Hope.

A diagnosis done for muscular dystrophy, spinal muscular atrophy, ALS, or any kind of rare condition is actually the most important, and the waiting lists for the clinical trials can stretch for years.
South Korea and Japan have emerged as the genuine destinations for the patients that have incurable and rare diseases. With Japan’s Act on Safety of Regenerative Medicine (ARMT), this rapid program was initiated for giving patients with intractable diseases or life-threatening diseases the advanced therapies with the evidence base that is still being gathered. The expanded program for ARMT in South Korea can provide similar access.
Emerge Medical Travel can work with the specialist hospitals and clinics for both these centuries, thus evaluating the full patient’s case individually and connecting it to the right treatment and therapy.

Most Popular Medical Treatments

Emerge Medical Travel connects international patients with India’s leading hospitals and respected specialists.
affordable care​

Stem Cell Therapy

iPSC and MSC-based programs for autoimmune and neurodegeneration along with rare metabolic conditions were government-approved in Korea and Japan.

expert dermatologists​

Japan ARMT Fast-Track

The regulatory fast-track system that includes intractable or life-threatening diseases, thus giving patients access months or years earlier than those standard approval timelines.

world class hospitals​

Accredited Hospitals

We work with Samsung Medical Center, NCNP Tokyo, and Seoul National University Hospital along with other leading rare disease centers in Korea and Japan.

skin cancer​

Clinical Trial Error

Korea and Japan have active clinical trials for SMA and ALS, along with neurological conditions, some free for those qualifying patients.

MRgFUS – knifeless brain procedure

Why Choose Japan & South Korea For Rare Disease Treatment With Emerge Medical Travel ?

Choosing the exact country for that rare disease treatment abroad is not only about finding the right kind of hospital; this is about finding out the regulatory pathways, the best specialist, and a team that can manage each detail for that complicated medical journey.

Conditions We Facilitate

For Emerge Medical Travel, we deeply connect the patients with the specialist hospitals in South Korea and Japan that have the experience towards treating those following rare and incurable conditions. Each case is evaluated individually towards the most appropriate treatment pathways:

cosmetic surgery​

ALS (Motor Neurone Disease)

Amyotrophic Lateral Sclerosis, which can cause the progressive loss of muscle control. Japan’s stem cell or NCNP programs for both these countries are based on MSC protocols that can slow neurodegeneration. Some of the clinical trials that are available for the qualifying patients.

limb lengthening procedures.​

Spinal Muscular Atrophy (SMA)

The SMA is defined as a genetic disorder that affects the motor neurons. Korea and Japan have active clinical research programs for the stem cell-based approaches for SMA patients that have exhausted standard treatment options.

bariatric surgery​

Duchenne Muscular Dystrophy

DMD can cause these muscle weaknesses for the dystrophin deficiency. Experimental gene therapy and stem cell therapy that have the adjacent that are available for the ARMT fast-tracking program.

bariatric surgery​

Rare Autoimmune Disorders

Conditions that include different forms of vasculitis and lupus and the inflammatory myopathies that can be candidates for MSC-based immunomodulation therapy that’s available for South Korea and Japan.

bariatric surgery​

Avascular Necrosis

A temporary or permanent loss of blood supply causes the bone tissue to die and eventually collapse. Total joint replacement is the most effective way to eliminate this severe pain.

advanced cancer care​

Other Incurable / Intractable Conditions

If your condition is not listed, submit your medical files to Emerge. The regulatory frameworks in Japan and Korea are built for rare disorders with no standard cure, and we assess every case individually.

What's Our Clients Says About us

Hear from our patients about their experiences and successful outcomes, reflecting the trust and quality care we provide.

Emerge Medical Travel guided me through every step of my treatment abroad. Their attention to detail and care made a stressful situation completely manageable.

    Tyler Morgan
    Tyler Morgan

    Thanks to Emerge Medical Travel, I had access to top specialists and world-class facilities. Their team was supportive, responsive, and professional throughout.

      Joshua Lane
      Joshua Lane

      From visa assistance to hospital coordination, Emerge Medical Travel handled everything seamlessly. I felt safe and well-cared-for during my medical journey.

        Austin Hayes
        Austin Hayes

        Choosing Emerge Medical Travel was the best decision for my treatment. Their personalized approach and expert guidance gave me complete peace of mind.

          Eric Vaughn
          Eric Vaughn

          Lots of Question in your mind?
          No, problem. We are here to answer all of them.

          Yes, Japan’s ARMT (Act on Safety for Regenerative Medicine) can fast-track what is achievable for international patients through those licensed clinics. Emerge Medical Travel can handle that eligibility assessment plus application process. Not all these conditions qualify, & we will assess every case individually.
          Yes, both countries have active trials like SMA and ALS, along with certain neurological disorders. Emerge Medical can identify the eligible trials that need no commitments.
          Submit the recent specialist reports, genetic tests, diagnostic letters, medication lists, and scans. Partial documentation is fine; we can advise on the missing items.
          No, we can guarantee honest case evaluation, transparent communication, and specialist submission. If the treatment is not suitable, we can tell that clearly.
          Scroll to Top
          Call Now Button